Türk Nöroşirürji Dergisi
2017 , Vol 27 , Num 2
Molecular Biology of Low Grade Gliomas
1Acıbadem Üniversitesi, Tıp Fakültesi, Nöroşirürji Anabilim Dalı, İstanbul, Türkiye
Low grade glioma (LGG) is a clinical definition that has originated from clinical modification of a pathological diagnosis. Tumors
defined by this term vary according to anatomical location, clinical behavior and response to treatment. This review aims to
define the historical evolution and the shortcomings of the LGG term, define clinically relevant molecular subsets and propose an
alternate classification. Benign and malignant forms of brain tumors were known since 1863. Through the years several unique
tumor biologies were defined and excluded from this classification. Novel molecular entities have defined further clinically relevant
subsets and have made LGG definition obsolete. The LGG term harbors astrocytomas, oligodendrogliomas and other tumors that
mimic these two entities (glioblastomas, expansile gliomas etc). Molecular markers have enabled a clinically much more relevant
definition of gliomas.
Anahtar Kelimeler :
Low grade glioma, Astrocytoma, Oligodendroglioma, 1p/19q co-deletion, IDH mutation